Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Amneal Pharmaceuticals, Inc. AMRX

Full chart Compare
Set alert

Price alert · AMRX

All alert types
20.21 USD -0.23 (-1.13%)

At closeNov 3, 2026, 6:35 PM EST

20.59 +0.38 +1.86%

After hours · Nov 3, 6:35 PM ET

19.68 Day range 20.81
11.19 52-week range 21.51
YTD
+60.40%
1 year
+80.61%

Financial health

Altman Z-Score

2.28 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 3
  • Return on Equity 5
  • Return on Assets 3
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E 54.8×
FY 2016: 12.0×FY 2017: 11.4×FY 2018: -10.2×FY 2019: -1.1×FY 2020: 7.5×FY 2021: 68.4×FY 2022: -2.3×FY 2023: -12.6×FY 2024: -20.8×FY 2025: 54.8×
FY 2016 5y median -2.3× FY 2025
P/S 1.3×
FY 2016: 2.5×FY 2017: 1.9×FY 2018: 1.0×FY 2019: 0.4×FY 2020: 0.3×FY 2021: 0.3×FY 2022: 0.1×FY 2023: 0.4×FY 2024: 0.9×FY 2025: 1.3×
FY 2016 5y median 0.4× FY 2025
P/B -55.8×
FY 2016: -13.5×FY 2017: -5.0×FY 2018: 1.9×FY 2019: 2.7×FY 2020: 2.2×FY 2021: 2.0×FY 2022: 1.0×FY 2023: 53.7×FY 2024: -22.4×FY 2025: -55.8×
FY 2016 5y median 1.0× FY 2025
P/FCF 14.6×
FY 2016: -262×FY 2017: 15.9×FY 2018: 11.2×FY 2019: -6.7×FY 2020: 2.1×FY 2021: 3.7×FY 2022: -11.8×FY 2023: 3.8×FY 2024: 11.1×FY 2025: 14.6×
FY 2016 5y median 3.8× FY 2025
EV/EBITDA 10.6×
FY 2016: 12.0×FY 2017: 12.3×FY 2018: -213×FY 2019: 21.0×FY 2020: 9.7×FY 2021: 8.3×FY 2022: 7.1×FY 2023: 7.4×FY 2024: 11.2×FY 2025: 10.6×
FY 2016 5y median 8.3× FY 2025
EV/Sales 2.1×
FY 2016: 3.6×FY 2017: 3.2×FY 2018: 2.5×FY 2019: 2.0×FY 2020: 1.7×FY 2021: 1.6×FY 2022: 1.4×FY 2023: 1.6×FY 2024: 1.8×FY 2025: 2.1×
FY 2016 5y median 1.6× FY 2025
FCF Yield 6.8%
FY 2016: -0.4%FY 2017: 6.3%FY 2018: 8.9%FY 2019: -15.0%FY 2020: 46.6%FY 2021: 27.2%FY 2022: -8.5%FY 2023: 26.0%FY 2024: 9.0%FY 2025: 6.8%
FY 2016 5y median 9.0% FY 2025

Profitability

Gross Margin 37.6%
FY 2016: 58.7%FY 2017: 50.9%FY 2018: 43.1%FY 2019: 21.7%FY 2020: 31.5%FY 2021: 36.7%FY 2022: 35.8%FY 2023: 36.1%FY 2024: 36.5%FY 2025: 37.6%
FY 2016 5y median 36.5% FY 2025
Operating Margin 14.0%
FY 2016: 28.0%FY 2017: 23.7%FY 2018: -1.2%FY 2019: -15.3%FY 2020: 4.6%FY 2021: 7.3%FY 2022: -4.3%FY 2023: 8.5%FY 2024: 8.9%FY 2025: 14.0%
FY 2016 5y median 8.5% FY 2025
Net Margin 2.4%
FY 2016: 20.4%FY 2017: 16.2%FY 2018: -10.2%FY 2019: -22.3%FY 2020: 4.6%FY 2021: 0.5%FY 2022: -5.9%FY 2023: -3.5%FY 2024: -4.2%FY 2025: 2.4%
FY 2016 5y median -3.5% FY 2025
ROE -101.8%
FY 2016: -111.9%FY 2017: -43.5%FY 2018: -18.9%FY 2019: -156.0%FY 2020: 30.0%FY 2021: 2.9%FY 2022: -43.6%FY 2023: -424.6%FY 2024: 107.0%FY 2025: -101.8%
FY 2016 5y median -43.6% FY 2025
ROIC 13.8%
FY 2016: 27.2%FY 2017: 21.4%FY 2018: -0.5%FY 2019: -7.9%FY 2020: -5.2%FY 2021: 3.0%FY 2022: -3.0%FY 2023: 7.2%FY 2024: 9.2%FY 2025: 13.8%
FY 2016 5y median 7.2% FY 2025
ROA 2.0%
FY 2016: 17.0%FY 2017: 12.5%FY 2018: -3.9%FY 2019: -9.9%FY 2020: 2.3%FY 2021: 0.3%FY 2022: -3.4%FY 2023: -2.4%FY 2024: -3.3%FY 2025: 2.0%
FY 2016 5y median -2.4% FY 2025

Growth (YoY)

Revenue 8.0%
FY 2016: 17.5%FY 2017: 1.5%FY 2018: 60.9%FY 2019: -2.2%FY 2020: 22.5%FY 2021: 5.1%FY 2022: 5.7%FY 2023: 8.2%FY 2024: 16.7%FY 2025: 8.0%
FY 2016 FY 2025
Operating Income 69.7%
FY 2016: 25.4%FY 2017: -14.0%FY 2018: -108.0%FY 2019: -1164.1%FY 2020: 136.7%FY 2021: 67.5%FY 2022: -162.2%FY 2023: 315.3%FY 2024: 22.0%FY 2025: 69.7%
FY 2016 FY 2025
EPS (diluted) 157.9%
FY 2016: 22.2%FY 2017: 32.7%FY 2018: -191.1%FY 2019: -243.6%FY 2020: 113.3%FY 2021: -88.5%FY 2022: -1328.6%FY 2023: 44.2%FY 2024: 20.8%FY 2025: 157.9%
FY 2016 FY 2025
Free Cash Flow 22.6%
FY 2016: 23.6%FY 2017: 1356.2%FY 2018: 27.7%FY 2019: -162.5%FY 2020: 431.3%FY 2021: -38.8%FY 2022: -113.1%FY 2023: 1184.1%FY 2024: -20.4%FY 2025: 22.6%
FY 2016 FY 2025

Financial Health

Current Ratio 2.2×
FY 2016: 3.2×FY 2017: 2.6×FY 2018: 2.3×FY 2019: 2.2×FY 2020: 2.3×FY 2021: 2.2×FY 2022: 1.9×FY 2023: 1.6×FY 2024: 1.4×FY 2025: 2.2×
FY 2016 5y median 1.9× FY 2025
Quick Ratio 1.5×
FY 2016: 2.0×FY 2017: 1.6×FY 2018: 1.5×FY 2019: 1.5×FY 2020: 1.6×FY 2021: 1.5×FY 2022: 1.2×FY 2023: 0.9×FY 2024: 0.9×FY 2025: 1.5×
FY 2016 5y median 1.2× FY 2025
Debt / Equity -38.7×
FY 2016: -6.5×FY 2017: -3.8×FY 2018: 3.0×FY 2019: 11.9×FY 2020: 9.9×FY 2021: 8.0×FY 2022: 9.5×FY 2023: 139×FY 2024: -23.7×FY 2025: -38.7×
FY 2016 5y median 8.0× FY 2025
Net Debt / EBITDA 4.0×
FY 2016: 3.8×FY 2017: 5.2×FY 2018: -126×FY 2019: 16.9×FY 2020: 7.7×FY 2021: 6.6×FY 2022: 6.4×FY 2023: 5.3×FY 2024: 5.6×FY 2025: 4.0×
FY 2016 5y median 5.6× FY 2025
Interest Coverage 1.8×
FY 2016: 5.2×FY 2017: 3.4×FY 2018: -0.1×FY 2019: -1.5×FY 2020: 0.6×FY 2021: 1.1×FY 2022: -0.6×FY 2023: 1.0×FY 2024: 1.0×FY 2025: 1.8×
FY 2016 5y median 1.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 8.0%FY 2017: 19.6%FY 2018: 10.6%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 96.7%FY 2017: 223.8%FY 2018: -107.8%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31